Pneumonia - Community-Acquired (Ped... : Follow Up | CIMS IN
  • Education
  •  Download App
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The CIMS logo.
  • Home
  • Find Drugs
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The CIMS logo.
  • Home
  • Find Drugs
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The CIMS logo.
Home
Find Drugs
Find Drug Company
Diseases
Medical News & Updates

Other Services
 Education
  Download App
Country
singapore
hong kong
malaysia
indonesia
thailand
philippines
vietnam
australia
korea
new zealand
Account
The CIMS logo.
  1. Diseases
  2. Pneumonia - Community-Acquired (Pediatric)
  3. ...
    • Diseases
    • Pneumonia - Community-Acquired (Pediatric)
  4. Follow Up

Pneumonia - Community-Acquired (Pediatric) Follow Up

Last updated: 10 July 2026
Reviewed by
MIMS Pediatrics Honorary Editorial Advisory Board
Follow Up
Monitoring
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyEtiologyPathophysiologyRisk Factors
Clinical PresentationHistoryPhysical ExaminationScreening
Laboratory Tests and AncillariesImaging
Differential Diagnosis
EvaluationPrinciples of TherapyPharmacological therapyNonpharmacologicalPrevention
Monitoring
AminoglycosidesAntibacterial CombinationCephalosporinsChloramphenicolMacrolidesOther AntibioticsOther Beta-LactamsPenicillinsQuinoloneTetracyclinesVaccinesDisclaimer
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyEtiologyPathophysiologyRisk Factors
Clinical PresentationHistoryPhysical ExaminationScreening
Laboratory Tests and AncillariesImaging
Differential Diagnosis
EvaluationPrinciples of TherapyPharmacological therapyNonpharmacologicalPrevention
Monitoring
AminoglycosidesAntibacterial CombinationCephalosporinsChloramphenicolMacrolidesOther AntibioticsOther Beta-LactamsPenicillinsQuinoloneTetracyclinesVaccinesDisclaimer

Monitoring

Predictors of treatment response are decrease in respiratory signs and defervescence within 48-72 hours of antimicrobial therapy. A switch to oral therapy may be considered once there is improvement in fever, cough, tachypnea, supplemental oxygen dependency, and increased activity and appetite, concurrent with a decrease in WBC counts and/or CRP levels. Children who developed lobar collapse, round pneumonia, or radiographic findings of community-acquired pneumonia complications may have an outpatient follow-up at 6-8 weeks with clinical evaluation and chest X-ray.

Specialist Referral

Consultation with a pediatric pulmonologist or infectious diseases specialist is considered if the patient has allergies, other coexisting illnesses, or the presence of complications (eg effusion, empyema, bronchiectasis, hemolytic uremic syndrome, necrotizing pneumonia, or sepsis); shows no clinical improvement despite receiving antibiotic therapy; and has recurrent pneumonia.

The CIMS logo.
  • Drugs
  • Find Drugs
  • Find Drug Company
  • CIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Editorial Advisory Board
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with CIMS
A social media brand icon.A social media brand icon.A social media brand icon.A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
CIMS Specialty v3.13.1
Copyright © 2026 CIMS Pte Ltd. All rights reserved. PRD
CIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.